Cheryl Gault, Chief Operating Officer of Rapport Therapeutics ($RAPP), made three open market sales of company stock over the past year, totaling about $400,000. Her most recent sale occurred on March 5, 2026. These transactions rank her 6,945th out of 11,678 insiders by sale value, well below the average of $8.6 million per insider across roughly 6.4 sales. Gault reported no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 30, 2026 | Rapport Therapeutics, Inc. | $RAPP | Gault Cheryl | Chief Operating Officer | S | Common Stock | 2839 | $28.55 | 159,914.0000 | 47,661,138 | 1.74% | 0.01% |
| March 30, 2026 | Rapport Therapeutics, Inc. | $RAPP | Gault Cheryl | Chief Operating Officer | S | Common Stock | 7161 | $28.04 | 162,753.0000 | 47,661,138 | 4.21% | 0.02% |
| March 5, 2026 | Rapport Therapeutics, Inc. | $RAPP | Gault Cheryl | Chief Operating Officer | S | Common Stock | 2014 | $28.93 | 169,914.0000 | 47,661,138 | 1.17% | 0.00% |
| Feb. 2, 2026 | Rapport Therapeutics, Inc. | $RAPP | Gault Cheryl | Chief Operating Officer | A | Stock Option (Right to Buy) | 132000 | $0.00 | 132,000.0000 | 47,661,138 | 9999.99% | 0.28% |
| Nov. 26, 2025 | Rapport Therapeutics, Inc. | $RAPP | Gault Cheryl | Chief Operating Officer | M | Common Stock | 5000 | $1.80 | 176,928.0000 | 47,661,138 | 2.91% | 0.01% |
| Nov. 26, 2025 | Rapport Therapeutics, Inc. | $RAPP | Gault Cheryl | Chief Operating Officer | S | Common Stock | 5000 | $30.10 | 171,928.0000 | 47,661,138 | 2.83% | 0.01% |
| Nov. 26, 2025 | Rapport Therapeutics, Inc. | $RAPP | Gault Cheryl | Chief Operating Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 105,407.0000 | 47,661,138 | 4.53% | 0.01% |
| Sept. 8, 2025 | Rapport Therapeutics, Inc. | $RAPP | Gault Cheryl | Chief Operating Officer | S | Common Stock | 5000 | $38.33 | 171,928.0000 | 36,496,437 | 2.83% | 0.01% |
| Sept. 8, 2025 | Rapport Therapeutics, Inc. | $RAPP | Gault Cheryl | Chief Operating Officer | M | Common Stock | 5000 | $1.80 | 176,928.0000 | 36,496,437 | 2.91% | 0.01% |
| Sept. 8, 2025 | Rapport Therapeutics, Inc. | $RAPP | Gault Cheryl | Chief Operating Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 110,407.0000 | 36,496,437 | 4.33% | 0.01% |
| March 3, 2025 | Rapport Therapeutics, Inc. | $RAPP | Gault Cheryl | Chief Operating Officer | A | Common Stock | 13987 | $0.00 | 171,928.0000 | 36,496,437 | 8.86% | 0.04% |
| Feb. 3, 2025 | Rapport Therapeutics, Inc. | $RAPP | Gault Cheryl | Chief Operating Officer | A | Stock Option (Right to Buy) | 129000 | $0.00 | 129,000.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2024 | Rapport Therapeutics, Inc. | $RAPP | Gault Cheryl | Chief Operations Officer | A | Stock Option (Right to Buy) | 88442 | $0.00 | 88,442.0000 | 0 | 9999.99% | 0.00% |